Biosimilars: The Generic-Style Savings for Biologic Drugs
By BetterBuyRx Editorial Team
Written for cost and savings education only — not medical advice, and not medically reviewed. Always confirm details with your doctor or pharmacist. See our methodology.
Last updated
Biosimilars are biologic medications that are highly similar to an already-approved reference biologic drug, with no clinically meaningful differences in safety or effectiveness, but they typically cost less. They differ from traditional generics because biologics are made from living cells rather than synthesized chemically, so a biosimilar can't be an exact chemical copy the way a generic pill is. Biosimilars still offer a real, generic-style path to lower costs for expensive biologic treatments.
Biologic drugs, including many treatments for chronic and complex conditions, are among the most expensive medications available. Biosimilars exist specifically to bring more competition and lower prices into that expensive category, using an approval approach built for the unique nature of biologic medicine.
What makes a drug a "biosimilar"
According to the FDA's biosimilar basics for patients, a biosimilar is a biological product that has been shown to be highly similar to, and to have no clinically meaningful differences from, an existing FDA-approved reference biologic. Biologics themselves are large, complex molecules typically produced from living cells or other biological sources, rather than the more straightforward chemical synthesis used for traditional small-molecule drugs. This complexity is exactly why biosimilars are evaluated under a different framework than standard generic drugs.
Search your medication on BetterBuyRx to check whether a biosimilar option exists for a biologic medication you're currently taking.
How biosimilars differ from traditional generics
A generic drug is a chemically identical copy of a small-molecule brand-name drug. A biosimilar, by contrast, is highly similar but not identical to its reference biologic, because biologics are grown from living organisms and involve enough natural manufacturing variability that an exact copy isn't scientifically possible in the same way. Despite not being identical, the FDA requires biosimilars to demonstrate no clinically meaningful difference in safety, purity, or potency compared to the reference product before approval.
Biosimilars vs. traditional generics at a glance
| Feature | Traditional generic | Biosimilar |
|---|---|---|
| Underlying drug type | Small-molecule chemical drug | Complex biologic (proteins, living-cell derived) |
| Relationship to original | Chemically identical copy | Highly similar, not identical |
| Manufacturing basis | Chemical synthesis | Living cells or biological sources |
| Approval standard | Bioequivalence | No clinically meaningful difference from reference biologic |
Why biosimilars tend to cost less
Biosimilar manufacturers benefit from a similar cost advantage to generic manufacturers: they can rely on the FDA's earlier finding that the reference biologic is safe and effective, rather than needing to fund a full, independent clinical trial program to establish that from scratch. According to the FTC's consumer guidance on biosimilars, this can translate into real savings for patients, since biosimilars are generally introduced at a lower price than the reference biologic once they reach the market. The exact savings depend on the specific drug, insurance coverage, and how many biosimilar competitors exist for that biologic.
Compare prescription prices on BetterBuyRx to see current pricing on biologic and biosimilar options where available, since the specific savings can vary substantially by medication and pharmacy.
Biosimilar insulin is a notable example
Insulin is now regulated as a biologic product, which has opened the door to biosimilar insulin versions becoming available. This regulatory shift matters because insulin costs have been a significant burden for many patients with diabetes, and biosimilar competition is one of the mechanisms now in place to help bring more competitive pricing into that specific category over time.
What biosimilar approval actually confirms
FDA approval of a biosimilar confirms that rigorous comparative testing found no clinically meaningful difference between the biosimilar and its reference product in terms of safety, purity, and potency. This is not a lower bar for safety, it's a different, biologic-specific pathway designed around the scientific realities of how these complex molecules are manufactured and compared. Check prices near you on BetterBuyRx to see how a biosimilar option might affect your specific out-of-pocket cost if one is available for your medication.
Ask your doctor and pharmacist before switching
Even though biosimilars are held to a rigorous FDA standard, switching from a reference biologic to a biosimilar, or vice versa, is a decision that should involve your prescriber. Your doctor can confirm whether a biosimilar is appropriate for your specific treatment plan, and your pharmacist can help you understand the cost difference and insurance coverage details for the biosimilar option.
The bottom line on biosimilars
Biosimilars bring a generic-style cost-saving mechanism to the biologic drug category, using a scientifically rigorous approval pathway built specifically for these complex medications. Compare prescription prices on BetterBuyRx to see what's available for your specific biologic medication. Prices vary by pharmacy, location, quantity, and eligibility.
Frequently asked questions
What exactly is a biosimilar?
A biosimilar is a biologic medication that is highly similar to an already FDA-approved reference biologic, with no clinically meaningful differences in safety or effectiveness. Biosimilars are made from living cells or other biological sources, unlike traditional generic drugs, which are manufactured through chemical synthesis.
Is a biosimilar the same thing as a generic drug?
No, though they serve a similar cost-saving purpose. Generic drugs are chemically identical copies of small-molecule brand drugs, while biosimilars are highly similar, but not identical, versions of complex biologic drugs, since biologics are grown from living organisms and can't be manufactured as an exact chemical copy.
Why can biosimilars cost less than the original biologic?
Biosimilar manufacturers can rely on the FDA's prior finding that the reference biologic is safe and effective, avoiding the need to repeat the full, expensive clinical trial program the original product went through. This lower development cost is a major reason biosimilars can be priced below the reference biologic.
Are biosimilar insulins available?
Yes. Since insulin is now regulated as a biologic product, biosimilar versions of certain insulins have become available, which the FDA notes can offer a lower-cost option for some patients.
Should I ask my doctor before switching to a biosimilar?
Yes. While biosimilars are FDA-approved to have no clinically meaningful differences from the reference product, only your doctor can determine whether switching is appropriate for your specific treatment plan, so this decision should always involve your prescriber or pharmacist.
Sources
Compare prices & find savings
This guide is for cost and savings education only. It is not medical advice. Talk to your doctor or pharmacist before making any changes to your medications. Prices vary by pharmacy, location, quantity, and eligibility, and they change over time.
Related guides
- How Generic Drugs Get Approved (and Why That Lowers Prices)
Generic drugs go through the FDA's ANDA process, proving bioequivalence rather than repeating clinical trials. Learn how this keeps generic prices lower.
- Authorized Generics: Brand Quality at Generic Prices
Authorized generics are brand-name drugs sold without the brand label. Learn how they differ from typical generics and why they can be cheaper.
- Generic vs Brand-Name Medications: Cost Differences Explained
How generic and brand-name medications differ in cost and FDA approval, with data on typical savings and what to ask your pharmacist.